Skip to content
StockMarketAgent
Healthcare / Medical Instruments & SuppliesUpdated 2026-05-10 22:07 UTC

MBOT stock hub

Microbot Medical Inc. has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

MBOTis not in this month’s coverageGet our monthly research letter — no spam
Fair value midpoint
n/a
Fair value pending
Upside to midpoint
n/a
Based on latest report
Confidence
n/a
Data quality and model convergence
Market cap
143M
NASDAQ
Market data

Live price

Current market quote for this ticker.

Current price
MBOT
In the news

Latest news · MBOT

Recent company headlines from major financial publishers.

Loading
Fetching the latest headlines.
Loading
Fetching the latest headlines.
Loading
Fetching the latest headlines.
Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming
DateLoading
Window
EPS estimate
Revenue estimate
Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/En/a
P25 12.3P50 18.4P75 33.1
Trailing P/En/a
P25 14.9P50 23.2P75 38.5
ROE-32.4
P25 -105.6P50 -46.5P75 -3.1
ROIC-22.5
P25 -63.1P50 -27.3P75 0.5
Benchmarks - 1M
S&P 500n/a
Nasdaq Compositen/a
Dow Jones Industrial Averagen/a
Russell 2000n/a
Indicator catalog

All MBOT market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields
180
Groups with data
11
Currency
USD
Showing 180 of 180 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

23
MetricValue
Cik
0000883975
Company name
Microbot Medical Inc.
Country
United States
Country code
US
Cusip
59503A204
Employees
43
Employees Change
23%
Employees Change Percent
115
Enterprise value
$65.3M
Exchange
NASDAQ
Financial currency
USD
First seen
2026-05-09
Industry
Medical Instruments & Supplies
Isin
US59503A2042
Last refreshed
2026-05-10
Market cap
$143M
Market cap category
Micro-Cap
Price
$2.13
Price currency
USD
Sector
Healthcare
Sic
3841
Symbol
MBOT
Website
https://microbotmedical.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

5
MetricValue
Earnings Yield
-9.19%
EV Sales Forward
15.01x
FCF yield
-9.16%
P/B ratio
1.84x
PS Forward
32.87x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

9
MetricValue
Net Income
$-13.1M
Net Income Growth Years
0%
Profit Per Employee
$-305,628
ROA
-21.04
Roa5y
-57.46
ROCE
-18.87
ROE
-32.42
Roe5y
-135.9
ROIC
-22.46

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

6
MetricValue
Cagr1y
-15.15%
Cagr3y
24.26%
Cagr5y
-21.25%
EPS Growth Quarters
13
EPS Growth Years
3
Revenue Growth Years
0x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

17
MetricValue
Assets
$81.5M
Cash
$78.6M
Current Assets
$79.8M
Current Liabilities
$3.4M
Debt
$865,000
Debt Equity
$0.01
Equity
$77.6M
Liabilities
$4M
Long Term Assets
$1.7M
Long Term Liabilities
$569,000
Net Cash
$77.7M
Net Cash By Market Cap
$54.34
Net Cash Growth
1,350.4%
Net Debt Equity
$-1
Tangible Book Value
$77.6M
Tangible Book Value Per Share
$1.15
WACC
10.01

Liquidity

Current-asset coverage and working-capital efficiency metrics.

4
MetricValue
Current ratio
23.33
Net Working Capital
$-1.9M
Quick ratio
23.04
Working Capital
$76.4M

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

2
MetricValue
Buyback Yield
-192.69%
Dividend Yield
0%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

37
MetricValue
1Y total return
-15.14%
200-day SMA
2.54
3Y total return
91.89%
50-day SMA
2.39
50-day SMA vs 200-day SMA
50under200
5Y total return
-69.7%
All Time High
192
All Time High Change
-98.89%
All Time High Date
2016-11-29
All Time Low
0.82
All Time Low Change
159.76%
All Time Low Date
2024-09-05
ATR
0.12
Beta
1.06
Beta1y
1.36
Beta2y
1.28
Ch YTD
6.5
High
2.15
High52
4.67
High52 Date
2025-09-08
High52ch
-54.39%
Low
2.1
Low52
1.6
Low52 Date
2026-02-05
Low52ch
33.13%
Ma50ch
-10.69%
Price vs 200-day SMA
-16.08%
RSI
42.95
RSI Monthly
48.15
RSI Weekly
45.92
Sharpe ratio
0.13x
Sortino ratio
0.3
Total Return
-192.69%
Tr YTD
6.5
Tr1m
-6.99%
Tr1w
1.43%
Tr3m
21.02%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

11
MetricValue
Analyst Count
3
Analyst Count Top
1
Analyst Price Target Top
$5.5
Analyst Ratings
Strong Buy
Analyst Ratings Top
Strong Buy
Earnings EPS Estimate
$-0.07
Earnings Revenue Estimate
490,000x
Operating Income
$-14.7M
Price target
$7.5
Price Target Change
$252
Price Target Change Top
$158

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

9
MetricValue
Float
67,158,044%
Float Percent
100%
Shares Institutions
17.56%
Shares Out
67,158,044
Shares Qo Q
39.94%
Shares Yo Y
192.69%
Short Float
12.75%
Short Ratio
5.46
Short Shares
12.75

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

57
MetricValue
Adjusted FCF
$-14.2M
Average Volume
1,459,297.3x
Bv Per Share
1.15
CAPEX
$-60,000
Ch1m
-6.99
Ch1w
1.43
Ch1y
-15.14
Ch3m
21.02
Ch3y
91.89
Ch5y
-69.7
Ch6m
3.9
Change
0%
Change From Open
0
Close
2.13
Days Gap
0
Depreciation Amortization
47,000
Dollar Volume
2,050,719.3
Earnings Date
2026-05-15
Earnings Time
amc
EBIT
$-14.7M
EBITDA
$-14.7M
EPS
$-0.29
F Score
2
FCF
$-13.1M
FCF EV Yield
-20.06x
FCF Per Share
$-0.2
Financing CF
86,240,000
Fiscal Year End
December
Founded
2,010
Investing CF
-72,384,000
Is Primary Listing
1
Is Spac
No
Last Earnings Date
2026-03-26
Last Report Date
2025-12-31
Last Split Date
2018-09-05
Last Split Type
Reverse
Last10k Filing Date
2026-03-26
Ma150
2.28
Ma150ch
-6.7%
Ma20
2.21
Ma20ch
-3.45%
Net CF
810,000
Next Earnings Date
2026-05-22
Open
2.13
Optionable
Yes
Position In Range
60
Post Close
2.13
Postmarket Change Percent
0.02
Postmarket Price
$2.13
Ppne
926,000
Price Date
2026-05-08
Ptbv Ratio
1.84
Relative Volume
0.66x
Share Based Comp
1,057,000
Tr6m
3.9%
Us State
Massachusetts
Volume
962,779
Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate
n/a
Named kill scenarios are reviewed before any bullish rating can stand.
Moat score
n/a
Business quality stays separate from stock attractiveness.
Forward P/E
n/a
Valuation uses the full report model stack, not a single multiple.
Next action
Research pending
Final action steps are kept in the recommendation tab.
Income

Does MBOT pay a dividend?

Capital-return profile for this ticker.

Performance

MBOT stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

1Y total return
-15.1%
S&P 500 1Y: n/a
3Y total return
+91.9%
S&P 500 3Y: n/a
5Y total return
-69.7%
S&P 500 5Y: n/a
10Y total return
n/a
S&P 500 10Y: n/a
Ownership

Who owns MBOT?

Insider, institutional, and short-interest positioning.

Institutional ownership
+17.6%
Float: +100.0% of shares outstanding
Insider ownership
n/a
Stake held by company insiders. Higher generally signals alignment.
Short interest
+12.8%
5.5 days to cover
Y/Y dilution
+192.7%
Negative means the company is buying back shares.
Technical

MBOT momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)
43.0
Neutral momentum band
Price vs 200-day MA
-16.1%
50/200-day relationship not available
Beta (5Y)
1.06
Moves roughly with the market
Sharpe ratio
0.13
Risk-adjusted return — higher is better; >1.0 is solid.
Questions

About MBOT

Hub-level FAQ points readers to the deeper analysis pages.

What is the current MBOT stock rating?

Microbot Medical Inc. is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full MBOT analysis?

The full report lives at /stocks/MBOT/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for MBOT?

The latest report frames MBOT around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the MBOT page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.